Prof. Dr. SELÇUK DAĞDELEN

Yayın Ağı

Makaleler 120

1. Anemia in acromegaly: Prevalence, etiologies, and predictors from a large tertiary center cohort

Yazgan B. F., Tekin S., ŞENDUR S. N., OĞUZ BAYKAL S. H., DAĞDELEN S., ERBAŞ A. T.

Pituitary , cilt.29, sa.1, 2026 (SCI-Expanded, Scopus)

2. An endocrinological point of view on a large series of pituitary stalk lesions

İŞLER A. O., ŞENDUR S. N., GÖÇMEN R., Soylemezoglu F., DAĞDELEN S., ERBAŞ A. T.

Pituitary , cilt.29, sa.1, 2026 (SCI-Expanded, Scopus)

3. Semaglutide and Hospitalizations in Patients With Obesity and Established Cardiovascular Disease: An Exploratory Analysis of the SELECT Randomized Clinical Trial.

Nicholls S. J., Ryan D. H., Deanfield J., Ferreira D., Lang C. C., Lincoff A. M., et al.

JAMA cardiology , cilt.11, sa.2, ss.156-164, 2026 (SCI-Expanded, Scopus)

4. Turkish version of the German Eating Behavior Scale (SEV-Tr): a study of reliability and construct validity

TÜRK Ö. P., DAĞDELEN S., Erbas T., BÜYÜKTUNCER DEMİREL Z.

PSYCHOLOGY HEALTH & MEDICINE , sa.4, ss.798-817, 2025 (SCI-Expanded, SSCI, Scopus)

5. Association of HIF-1α and TNFα single nucleotide polymorphisms with periodontal disease in diabetic patients

Kucukyurt S., YILDIRIM Y. D., Helvaci N., kabaçam s., özdemir y., DIKMEER A., et al.

Acta Medica , cilt.56, sa.1, ss.19-26, 2025 (TRDizin)

6. Investigating how eating behavior shapes mental health: A cross-sectional study

TÜRK Ö. P., Tosun O., DAĞDELEN S., BÜYÜKTUNCER DEMİREL Z.

PHYSIOLOGY & BEHAVIOR , 2025 (SCI-Expanded, SSCI, Scopus)

7. **Unveiling a novel INPP5E mutation: Bridging the gap between Joubert Syndrome and MORM Syndrome**

Bulut N., OĞUZ BAYKAL S. H., DAĞDELEN S., GÜLERAY LAFCI N.

EUROPEAN JOURNAL OF HUMAN GENETICS , ss.1352, 2024 (SCI-Expanded, Scopus)

8. Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial.

Deanfield J., Verma S., Scirica B. M., Kahn S. E., Emerson S. S., Ryan D., et al.

Lancet (London, England) , cilt.404, sa.10454, ss.773-786, 2024 (SCI-Expanded, Scopus)

9. SEMAGLUTIDE, INFLAMMATORY MARKERS AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH OVERWEIGHT OR OBESITY IN THE SELECT TRIAL

Plutzky J., Bogdanski P., DAĞDELEN S., Deanfield J., Emerson S., Hovingh G., et al.

ATHEROSCLEROSIS , 2024 (SCI-Expanded, Scopus)

10. 1899-LB: The Predictors and Management of Eating Disorders in Adult Patients with Type 1 Diabetes Mellitus

Sasmazer B., Yıldız M. I., Keles S., Oguz S. H., Sendur S. N., Ünlütürk U., et al.

DIABETES , cilt.73, sa.1, ss.1899, 2024 (SCI-Expanded, Scopus)

11. Evaluation of the relation between subclinical systolic dysfunction defined by four-dimensional speckle-tracking echocardiography and growth differentiation factor-15 levels in patients with acromegaly

Fırlatan B., Karakulak U. N., Hekimsoy V., Iremli B. G., Lay İ., Yüce D., et al.

Hormones , 2024 (SCI-Expanded, Scopus)

12. Effectiveness and Safety of Initiation and Titration of Insulin Glargine 300 U/mL in Insulin-Naive Patients with Type 2 Diabetes Mellitus Uncontrolled on Oral Antidiabetic Drug Treatment in Turkey: The EASE Study

ARSLAN B., Çetinkalp Ş., Kaya A., ERSOY C., Kebapçı N., ÇÖMLEKÇİ A., et al.

Endocrinology Research and Practice , cilt.28, sa.1, ss.4-11, 2024 (Scopus, TRDizin)

13. Glycemic variability leads to higher levels of auto-oxidized oxysterol species in patients with type 1 diabetes mellitus

ÜNLÜTÜRK U., Bahçecioğlu A., Samadi A., LAY İ., BAYRAKTAR M., DAĞDELEN S.

Journal of Endocrinological Investigation , cilt.46, sa.12, ss.2547-2554, 2023 (SCI-Expanded, Scopus)

14. Giant growh hormone-secreting pituitary adenomas from the endocrinologist's perspective.

Koylu B., Firlatan B., Sendur S. N., Oguz S. H., Dagdelen S., Erbas T.

Endocrine , cilt.79, sa.3, ss.545-553, 2023 (SCI-Expanded, Scopus)

15. The Clinical Characteristics and Outcomes of COVID-19 Patients with Pre-Existing Thyroid Dysfunction: A Nationwide Study

Sahin M., Demirci I., Haymana C., Tasci I., Emral R., Cakal E., et al.

HORMONE AND METABOLIC RESEARCH , sa.01, ss.25-30, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

16. Follow, consider, and catch: second primary tumors in acromegaly patients.

Oguz S. H., Firlatan B., Sendur S. N., Dagdelen S., Erbas T.

Endocrine , cilt.80, ss.160-173, 2022 (SCI-Expanded, Scopus)

17. Energy expenditure and glucose-lowering effect of different exercise modalities in diabetes mellitus

Bozdemir-Ozel C., Arikan H., Çalik-Kutukcu E., Karaduz B. N., Inal-Ince D., Kabakci G., et al.

PHYSIOTHERAPY , cilt.117, ss.97-103, 2022 (SCI-Expanded, Scopus)

18. Reduced irisin levels in patients with acromegaly

Şendur S. N., Baykal G., Fırlatan B., Aydin B., Lay İ., Dağdelen S., et al.

HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION , cilt.43, sa.3, ss.251-261, 2022 (ESCI, Scopus)

19. Discrimination between non-functioning pituitary adenomas and hypophysitis using machine learning methods based on magnetic resonance imaging-derived texture features

Sahin S., Yildiz G., Oguz S. H., Civan O., Cicek E., Durcan E., et al.

PITUITARY , cilt.25, sa.3, ss.474-479, 2022 (SCI-Expanded, Scopus)

20. No association of Gaucher disease with COVID-19-related outcomes: a nationwide cohort study

Demirci I., DEMİR T., DAĞDELEN S., Haymana C., Tasci I., ATMACA A., et al.

INTERNAL MEDICINE JOURNAL , cilt.52, ss.379-385, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

21. Higher rate of COVID-19 mortality in patients with type 1 than type 2 diabetes: A nationwide study

Demirci I., Haymana C., Tasci I., SATMAN İ., Atmaca A., ŞAHİN M., et al.

Endokrynologia Polska , cilt.73, sa.1, ss.87-95, 2022 (SCI-Expanded, Scopus)

22. Clinical Characteristics and Outcomes of COVID-19 Patients with Overweight and Obesity: Turkish Nationwide Cohort Study (TurCObesity)

Sahin I., Haymana C., Demir T., Demirci I., Tasci I., Atmaca A., et al.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , sa.02, ss.115-124, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

23. No association of anti-osteoporosis drugs with COVID-19-related outcomes in women: a nationwide cohort study

Atmaca A., Demirci I., Haymana C., Tasci I., ŞAHİN İ., Cakal E., et al.

OSTEOPOROSIS INTERNATIONAL , sa.1, ss.273-282, 2022 (SCI-Expanded, Scopus)

24. Expert Panel Recommendations for Use of Standardized Glucose Reporting System Based on Standardized Glucometrics Plus Visual Ambulatory Glucose Profile (AGP) Data in Clinical Practice

Dağdelen S., Deyneli O., Dinccag N., Ilkova H., Osar Siva Z., Yetkin İ., et al.

FRONTIERS IN ENDOCRINOLOGY , cilt.12, 2022 (SCI-Expanded, Scopus)

25. 68Ga-DOTATATE PET/CT in Pituitary Carcinoma.

Kaya G., Soydas Turan B., Dagdelen S., Berker M., Tuncel M.

Clinical nuclear medicine , cilt.46, ss.996-998, 2021 (SCI-Expanded, Scopus)

26. Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study

Emral R., Haymana C., Demirci I., Tasci I., Sahin M., Cakal E., et al.

DIABETES THERAPY , sa.11, ss.2857-2870, 2021 (SCI-Expanded, Scopus)

27. The clinical outcomes of COVID-19 infection in patients with a history of thyroid cancer: A nationwide study

Sahin M., Haymana C., Demirci I., Tasci I., Rıfat E., Unluturk U., et al.

CLINICAL ENDOCRINOLOGY , sa.4, ss.628-637, 2021 (SCI-Expanded, Scopus)

28. Clinical outcomes of non-diabetic COVID-19 patients with different blood glucose levels: a nationwide Turkish study (TurCoGlycemia)

Haymana C., Demirci I., Tasci I., Cakal E., Salman S., Ertugrul D., et al.

ENDOCRINE , sa.2, ss.261-269, 2021 (SCI-Expanded, Scopus)

29. Clinical characteristics and outcomes of COVID-19 in patients with type 2 diabetes in Turkey: A nationwide study (TurCoviDia)

Sonmez A., Demirci I., Haymana C., Tasci I., Dagdelen S., Salman S., et al.

JOURNAL OF DIABETES , sa.7, ss.585-595, 2021 (SCI-Expanded, Scopus)

30. Long-Term Outcomes of Tamoxifen Citrate Therapy and Histo- and Immunopathological Properties in Riedel Thyroiditis

Gokcay Canpolat A., Cinel M., Dizbay Sak S., Taskaldiran I., Korkmaz H., Demir Ö., et al.

EUROPEAN THYROID JOURNAL , cilt.10, sa.3, ss.248-256, 2021 (SCI-Expanded, Scopus)

31. Klotho gene G395A and C1818T polymorphisms in acromegaly: Association with clinical presentation and comorbidities.

Helvaci N., Kabacam S., Dagdelen S., Lay İ., Karabulut E., Mut M., et al.

Clinical endocrinology , cilt.94, sa.4, ss.598-605, 2021 (SCI-Expanded, Scopus)

32. Unexpectedly lower mortality rates in COVID-19 patients with and without type 2 diabetes in Istanbul

Satman I., Demirci I., Haymana C., Tasci I., Salman S., Ata N., et al.

DIABETES RESEARCH AND CLINICAL PRACTICE , 2021 (SCI-Expanded, Scopus)

33. Management of patients with diabetes and obesity in the COVID-19 era: experiences and learnings from South and East Europe, the Middle East, and Africa.

Giorgino F., Bhana S., Czupryniak L., Dagdelen S., Galstyan G. R., Janež A., et al.

Diabetes research and clinical practice , cilt.172, 2021 (SCI-Expanded, Scopus)

34. Investigation of cardiovascular disease risk factors knowledge and physical activity levels in patients with type 2 diabetes

BOZDEMİR ÖZEL C., ARIKAN H., DAĞDELEN S., ÇALIK KÜTÜKCÜ E., KARADÜZ B. N., KABAKCI M. G., et al.

Journal of Exercise Therapy and Rehabilitation , cilt.8, sa.1, ss.99-105, 2021 (TRDizin)

35. Tip 2 diyabetli bireylerde kardiyovasküler hastalıklar risk faktörleri bilgi düzeyi ve fiziksel aktivite seviyelerinin incelenmesi

BOZDEMİR ÖZEL C., ARIKAN H., DAĞDELEN S., ÇALIK KÜTÜKCÜ E., Karadüz B. N., KABAKCI M. G., et al.

Journal of Exercise Therapy and Rehabilitation , cilt.8, sa.1, ss.99-105, 2021 (TRDizin)

36. Probable alterations in fecal bacterial microbiota by somatostatin receptor analogs in acromegaly

ŞENDUR S. N., ERGÜNAY K., Akyon Y., Brinkmann A., Serdar M., DAĞDELEN S., et al.

TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , cilt.45, sa.6, ss.695-700, 2020 (SCI-Expanded, Scopus, TRDizin)

37. Use of SGLT2 inhibitors during Ramadan: An expert panel statement.

Hassanein M., Bashier A., Randeree H., Abouelmagd M., AlBaker W., Afandi B., et al.

Diabetes research and clinical practice , cilt.169, ss.108465, 2020 (SCI-Expanded, Scopus)

38. İNSİDENTAL ADRENAL LEZYONLARIN KLİNİK, HORMONAL VE HİSTOLOJİK DEĞERLENDİRİLMESİ: TEK MERKEZ SONUÇLARI

Akın Ş., DAĞDELEN S., YILDIZ O. B., Gurlek A., ERBAŞ T., BAYRAKTAR M.

Kocatepe Tıp Dergisi , cilt.21, sa.1, ss.150-156, 2020 (TRDizin)

39. İNSİDENTAL ADRENAL LEZYONLARIN KLİNİK, HORMONAL VE HİSTOLOJİKDEĞERLENDİRİLMESİ: TEK MERKEZ SONUÇLAR

Akın Ş., DAĞDELEN S., YILDIZ O. B., Gurlek A., ERBAŞ T., BAYRAKTAR M.

Kocatepe Tıp Dergisi , cilt.21, sa.2, ss.150-156, 2020 (TRDizin)

40. Subclinical Inflammation Is Associated With Reductions in Muscle Oxygenation, Exercise Capacity and Quality of Life in Adults With Type 2 Diabetes

BOZDEMİR ÖZEL C., Arikan H., ÇALIK KÜTÜKCÜ E., Karaduz B. N., İNAL İNCE D., Kabakci G., et al.

CANADIAN JOURNAL OF DIABETES , cilt.44, sa.5, ss.422-427, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

41. A greater proportion of participants with type 2 diabetes achieve treatment targets with insulin degludec/liraglutide versus insulin glargine 100 units/mL at 26 weeks: DUAL VIII, a randomized trial designed to resemble clinical practice

Sesti G., Bardtrum L., DAĞDELEN S., Halladin N., Haluzik M., Orsy P., et al.

DIABETES OBESITY & METABOLISM , cilt.22, sa.5, ss.873-878, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

42. MON-303 Giant Growth Hormone Secreting Pituitary Adenomas: A Single Institution Case Series.

B K., Sn S., Sh O., Dağdelen S., Ta E.

JOURNAL OF THE ENDOCRINE SOCIETY , cilt.4, sa.Supp1, ss.303, 2020 (ESCI, Scopus)

43. Clinical Characteristics, Management, and Treatment Outcomes of Primary Hypophysitis: A Monocentric Cohort

Oguz S. H., Soylemezoglu F., ŞENDUR S. N., Mut M., Oguz K. K., DAĞDELEN S., et al.

HORMONE AND METABOLIC RESEARCH , cilt.52, sa.4, ss.220-227, 2020 (SCI-Expanded, Scopus)

44. A case of atypical macroprolactinoma presenting with pituitary apoplexy during pregnancy and review of the literature

OĞUZ BAYKAL S. H., Soylemezoglu F., DAĞDELEN S., Erbas T.

GYNECOLOGICAL ENDOCRINOLOGY , cilt.36, sa.2, ss.109-116, 2020 (SCI-Expanded, Scopus)

45. Better Outcomes With Minimally Invasive Thyroidectomy Than Conventional Thyroidectomy

SÜSLÜ N., KÜLEKCİ C., DAĞDELEN S., HELVACI N., ERBAŞ A. T.

Acta Medica , cilt.50, sa.4, ss.8-13, 2019 (TRDizin)

46. A case of Woodhouse-Sakati syndrome with pituitary iron deposition, cardiac and intestinal anomalies, with a novel mutation in DCAF17

ŞENDUR S. N., OĞUZ S., ÜTİNE G. E., DAĞDELEN S., Oguz K. K., Erbas T., et al.

EUROPEAN JOURNAL OF MEDICAL GENETICS , cilt.62, sa.8, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

47. Assessment of static and dynamic plantar data of patients with acromegaly

ŞENDUR S. N., Oguz S. H., DAĞDELEN S., Erbas T.

PITUITARY , cilt.22, sa.4, ss.373-380, 2019 (SCI-Expanded, Scopus)

48. SUN-352 Estrogen, Progesterone, and Androgen Receptor Expressions Predict the Prognosis for Adrenocortical Carcinoma.

S O., C S., M B., S D.

JOURNAL OF THE ENDOCRINE SOCIETY , cilt.3, sa.Suppl1, ss.352, 2019 (Scopus)

49. MON-113 Taste Sensitivity is Related to Incretin Response to Oral Glucose Challenge, Dietary Habits and Body Composition: A Novel Link with Energy Metabolism.

Dağdelen S., S A., T S., C S., B F., I L., et al.

JOURNAL OF THE ENDOCRINE SOCIETY , cilt.3, sa.Suppl1, ss.113, 2019 (Scopus)

50. Turkish Insulin Injection Techniques Study: Complications of Injecting Insulin Among Turkish Patients with Diabetes, Education They Received, and the Role of Health Care Professional as Assessed by Survey Questionnaire

DAĞDELEN S., Deyneli O., OLGUN N., Siva Z. O., SARGIN M., Hatun S., et al.

DIABETES THERAPY , cilt.9, sa.4, ss.1615-1628, 2018 (SCI-Expanded, Scopus)

51. Turkish Insulin Injection Technique Study: Population Characteristics of Turkish Patients with Diabetes Who Inject Insulin and Details of Their Injection Practices as Assessed by Survey Questionnaire

DAĞDELEN S., Deyneli O., OLGUN N., Siva Z. O., SARGIN M., Hatun S., et al.

DIABETES THERAPY , cilt.9, sa.4, ss.1629-1645, 2018 (SCI-Expanded, Scopus)

52. Relation of RANKL and OPG Levels with Bone Resorption in Patients with Acromegaly and Prolactinoma

Ozer F. F., DAĞDELEN S., Erbas T.

HORMONE AND METABOLIC RESEARCH , cilt.50, sa.7, ss.562-567, 2018 (SCI-Expanded, Scopus)

53. Gycaemic variability is associated with oxidative damage indepently from glycaemic control in type 1 diabetes.

DAĞDELEN S., BAHÇECİOĞLU MUTLU A. B., LAY İ., SAMADİ A., ÜNLÜTÜRK U., BAYRAKTAR M.

Diabetologia , cilt.60, ss.1105, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

54. Liraglutide and Renal Outcomes in Type 2 Diabetes.

Mann J. F. E., Ørsted D. D., Brown-Frandsen K., Marso S. P., Poulter N. R., Rasmussen S., et al.

The New England journal of medicine , cilt.377, sa.9, ss.839-848, 2017 (SCI-Expanded, Scopus)

55. Unusual presentations of Carney Complex in patient with a novel PRKAR1A mutation

AKİN S., NOYAN S., DAĞDELEN S., Pasaoglu I., KAYNAROGLU V., MUT AŞKUN M., et al.

Neuroendocrinology Letters , cilt.38, ss.248-254, 2017 (SCI-Expanded, Scopus)

56. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

Marso S. P., Daniels G. H., Brown-Frandsen K., Kristensen P., Mann J. F. E., Nauck M. A., et al.

The New England journal of medicine , cilt.375, sa.4, ss.311-22, 2016 (SCI-Expanded, Scopus)

57. Distribution of RET Mutations and Evaluation of Treatment Approaches in Hereditary Medullary Thyroid Carcinoma in Turkey

Aydogan B. I., Yuksel B., Tuna M. M., Basaran M. N., Kocaeli A. A., Ertorer M. E., et al.

JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY , cilt.8, sa.1, ss.13-20, 2016 (SCI-Expanded, Scopus, TRDizin)

58. Genetic Alterations in Differentiated Thyroid Cancer Patients with Acromegaly

Aydin K., Aydin C., Dagdelen S., Tezel G. G., Erbas T.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , cilt.124, sa.3, ss.198-202, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

59. Comparison of Early Total Thyroidectomy with Antithyroid Treatment in Patients with Moderate-Severe Graves' Orbitopathy: A Randomized Prospective Trial

Erdogan M. F., DEMİR Ö., ERSOY R., Gul K., Aydogan B. I., Uc Z. A., et al.

EUROPEAN THYROID JOURNAL , cilt.5, sa.2, ss.106-111, 2016 (SCI-Expanded, Scopus)

60. The clinical and cardiometabolic effects of d3-growth hormone receptor polymorphism in acromegaly

Cinar N., Dağdelen S., Yorgun H., Canpolat U., Kabakci G., Erbas T.

PITUITARY , cilt.18, sa.1, ss.116-125, 2015 (SCI-Expanded, Scopus)

61. Serum Adiponectin Levels and Changes in Glucose Metabolism before and after Treatment for Thyroid Dysfunction

Ozdemir D., DAĞDELEN S., Usman A.

INTERNAL MEDICINE , cilt.54, sa.15, ss.1849-1857, 2015 (SCI-Expanded, Scopus)

62. Increased thyroid cancer risk in acromegaly

DAĞDELEN S., Cinar N., Erbas T.

PITUITARY , cilt.17, sa.4, ss.299-306, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

63. Recurrent parathyroid carcinoma with spinal metastases unresponsive to cinacalcet therapy

SENDUR M. A. N., DAĞDELEN S., ABBASOĞLU O., Erbas B., SÖKMENSÜER C., ZIYAL I., et al.

JOURNAL OF BUON , cilt.19, sa.3, ss.863-864, 2014 (SCI-Expanded, Scopus)

64. Genetic Alterations in Differentiated Thyroid Cancer Patients with Acromegaly

Aydin K., Aydin C., DAĞDELEN S., Tezel G. G., Erbas T.

ENDOCRINE REVIEWS , cilt.35, sa.3, 2014 (SCI-Expanded, Scopus)

65. Genetic Alterations in Differentiated Thyroid Cancer Patients with Acromegaly

Aydin K., Aydin C., DAĞDELEN S., Tezel G. G., Erbas T.

ENDOCRINE REVIEWS , cilt.35, sa.3, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

66. Assessment of the Microcirculation in Vivo with Nailfold Videocapillaroscopy in Acromegaly

DAĞDELEN S., Akin S., Kilic E., AKDOĞAN A., Erbas T.

ENDOCRINE REVIEWS , cilt.35, sa.3, 2014 (SCI-Expanded, Scopus)

67. Association Between ACE and AGT Polymorphism and Cardiovascular Risk in Acromegalic Patients

ERBAS T., CINAR N., DAĞDELEN S., GEDIK A., YORGUN H., CANPOLAT U., et al.

ENDOCRINE REVIEWS , cilt.35, sa.3, 2014 (SCI-Expanded, Scopus)

68. Assessment of cardiac autonomic functions by heart rate recovery, heart rate variability and QT dynamicity parameters in patients with acromegaly

Dural M., Kabakci G., Cinar N., Erbas T., Canpolat U., Gurses K. M., et al.

PITUITARY , cilt.17, sa.2, ss.163-170, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

69. Pituitary Corticotroph Microadenomas Versus Macroadenomas Causing Cushing’s Disease

Aydin K., Dağdelen S., Özgen B., Oruçkaptan H., Söylemezoğlu A. F., Erbaş A. T.

AUSTRIAN JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM , cilt.7, sa.3, ss.96-101, 2014 (Scopus)

70. Evaluation of thyroid diseases and differentiated thyroid cancer in acromegalic patients

DOGAN S., ATMACA A., DAĞDELEN S., Erbas B., ERBAS T.

ENDOCRINE , cilt.45, sa.1, ss.114-121, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

71. Diagnosis of acromegaly: Role of the internist and the other medical professionals

Aydin K., Cinar N., DAĞDELEN S., Erbas T.

EUROPEAN JOURNAL OF INTERNAL MEDICINE , cilt.25, sa.2, 2014 (SCI-Expanded, Scopus)

72. Cavernous sinus invasion might be a risk factor for apoplexy

Cinar N., Tekinel Y., DAĞDELEN S., Oruckaptan H., Soylemezoglu F., Erbas T.

PITUITARY , cilt.16, sa.4, ss.483-489, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

73. Voice characteristics of acromegaly

Aydin K., Turkyilmaz D., Ozturk B., DAĞDELEN S., Ozgen B., Unal F., et al.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY , cilt.270, sa.4, ss.1391-1396, 2013 (SCI-Expanded, Scopus)

74. Bluish Discoloration with Thyrotoxicosis

Akin S., DAĞDELEN S.

TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM , cilt.17, sa.2, ss.52, 2013 (ESCI, Scopus)

75. Plasma Osteoprotegerin Levels Before and After Treatment of Thyroid Dysfunctions

Ozdemir D., DAĞDELEN S., Usman A.

TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM , cilt.17, sa.4, ss.102-107, 2013 (ESCI, Scopus)

76. Spontaneous remission of acromegaly after infarctive apoplexy with a possible relation to MRI and diabetes mellitus

Cinar N., METİN Y., DAĞDELEN S., Ziyal M. I., Soylemezoglu F., Erbas T.

NEUROENDOCRINOLOGY LETTERS , cilt.34, sa.5, ss.339-342, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

77. Extremely high parathyroid hormone concentrations associated with pityriasis rubra pilaris and monoclonal gammopathy of unknown significance: A clinical dilemma

Tanriover M., Portakal O., Hapa A., Tekinel Y., DAĞDELEN S., BÜYÜKAŞIK Y., et al.

BONE , cilt.51, sa.5, ss.847-850, 2012 (SCI-Expanded, Scopus)

78. Changing clinical characteristics of thyroid carcinoma at a single center from Turkey: before and after the Chernobyl disaster

Özdemir D. M., Dağdelen S., Kıratlı P., Tuncel M., Erbas B., Erbas T.

MINERVA ENDOCRINOLOGICA , cilt.32, sa.3, ss.267-274, 2012 (SCI-Expanded, Scopus)

79. Changing clinical characteristics of thyroid carcinoma at a single center from Turkey: before and after the Chernobyl disaster.

Ozdemir D., Dagdelen S., Kiratli P., Tuncel M., Erbas B., Erbas T.

Minerva endocrinologica , cilt.37, sa.3, ss.267-74, 2012 (SCI-Expanded, Scopus)

80. Functional and structural evaluation of hearing in acromegaly

Aydin K., Ozturk B., Turkyilmaz M. D., DAĞDELEN S., Ozgen B., Unal F., et al.

CLINICAL ENDOCRINOLOGY , cilt.76, sa.3, ss.415-419, 2012 (SCI-Expanded, Scopus)

81. Systemic Mastocytosis

Ozdemir D., DAĞDELEN S., Erbas T.

AMERICAN JOURNAL OF THE MEDICAL SCIENCES , cilt.342, sa.5, ss.409-415, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

82. Amyloid goiter and hypopituitarism in a patient with systemic amyloidosis

OZDEMIR D., DAĞDELEN S., ERBAS T., SÖKMENSÜER C., Erbas B., CILA A.

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS , cilt.18, sa.1, ss.32-34, 2011 (SCI-Expanded, Scopus)

83. ENDOCRINE INVOLVEMENT IN SYSTEMIC AMYLOIDOSIS

Ozdemir D., Dagdelen S., Erbas T.

ENDOCRINE PRACTICE , cilt.16, sa.6, ss.1056-1063, 2010 (SCI-Expanded, Scopus)

84. Verapamil stimulation test in hyperprolactinemia: loss of prolactin response in anatomic or functional stalk effect

Dagdelen S., Usman A.

MINERVA ENDOCRINOLOGICA , cilt.35, sa.2, ss.53-59, 2010 (SCI-Expanded, Scopus)

85. Disease of the Sultans: metabolic syndrome in Ottoman dynasty

DAĞDELEN S., Erbas T.

ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY , cilt.10, sa.3, ss.270-273, 2010 (SCI-Expanded, Scopus, TRDizin)

86. Association Between Prol2Ala Polymorphism of Peroxisome ProliferatorActivated Receptor Gamma (PPAR gamma) and Components of Metabolic Syndrome

BÜYÜKTUNCER DEMİREL Z., KÖKSAL G., DAĞDELEN S., Geyik P. O., Isildak M., Erbas T.

TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM , cilt.14, sa.3, ss.54-59, 2010 (ESCI, Scopus) Sürdürülebilir Kalkınma

87. Association between Pro12Ala polymorphism of peroxisome proliferator-activated receptor gamma (PPARγ) and components of metabolic syndrome Metabolik sendromda peroksizom proliferator-aktive edici Gamma (PPARγ Pro12Ala genotipinin sendrom bilȩenlerine etkisi ve diyet ile Etkileşimi

Büyüktuncer Z., Köksal G., DAǦDELEN S., GEYIK P. O., IŞIDAK M., ERBAS T.

Turkish Journal of Endocrinology and Metabolism , cilt.14, sa.3, ss.54-59, 2010 (SCI-Expanded, Scopus)

88. Hypotension, Syncope, and Fever in Systemic Mastocytosis without Skin Infiltration and Rapid Response to Corticosteroid and Cyclosporin: A Case Report

Ozdemir D., DAĞDELEN S., Erbas T., AĞBAHT K., Serefhanoglu S., AKSU S., et al.

CASE REPORTS IN MEDICINE , 2010 (ESCI, Scopus)

89. Toward Better Models of Hyperthyroid Graves' Disease

Dagdelen S., Kong Y. M., Banga J. P.

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA , cilt.38, sa.2, ss.343-355, 2009 (SCI-Expanded, Scopus)

90. Impact of renin-angiotensin system polymorphisms on renal haemodynamic responsiveness to acute angiotensin-converting enzyme inhibition in type 2 diabetes mellitus

VOLKAN-SALANCI B., DAĞDELEN S., ALİKAŞİFOĞLU M., ERBAS T., HAYRAN M., Erbas B.

JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM , cilt.10, sa.1, ss.41-50, 2009 (SCI-Expanded, Scopus)

91. Simultaneous triple organ specific autoantibody profiling in adult patients with type 1 diabetes mellitus and their first-degree relatives

Dagdelen S., Hascelik G., Bayraktar M.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , cilt.63, sa.3, ss.449-456, 2009 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

92. The Role of Thyroid Scintigraphy in Hashimoto Thyroiditis: Comparison with Clinical and Ultrasonographic Findings.

Caglar M., Ergun E., Dagdelen S.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.35, 2008 (SCI-Expanded, Scopus)

93. Diabetic Cardiovascular Disease Lost in Translation Between Endocrinology and Cardiology

Dagdelen S.

AMERICAN JOURNAL OF CARDIOLOGY , cilt.102, sa.8, ss.1115-1116, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

94. Pituitary hypoplasia and growth hormone deficiency in a woman with glycogen storage disease type Ia: A case report

DAĞDELEN S., Atmaca A., Alikasifoglu A., Erbas T.

Journal of Medical Case Reports , cilt.2, 2008 (Scopus)

95. Humoral hypercalcemia of benignancy secondary to parathyroid hormone-related protein secreting uterine leiomyoma

DAĞDELEN S., Kalan I., Gurlek A.

AMERICAN JOURNAL OF THE MEDICAL SCIENCES , cilt.335, sa.5, ss.407-408, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

96. Global confusion on the diagnostic criteria for metabolic syndrome: What is the point that guidelines can not agree?

DAĞDELEN S., Yildirim T., Erbas T.

ANATOLIAN JOURNAL OF CARDIOLOGY , cilt.8, sa.2, ss.149-153, 2008 (SCI-Expanded, Scopus, TRDizin)

97. Rosiglitazone-induced anasarca without heart failure: capillary leakage?

DAĞDELEN S., Kurt M., Aydin K., BAYRAKTAR M.

HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM , cilt.7, sa.2, ss.180-183, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

98. [Global confusion on the diagnostic criteria for metabolic syndrome: what is the point that guidelines can not agree?].

Dağdelen S., Yildirim T., Erbaş T.

Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology , cilt.8, sa.2, ss.149-53, 2008 (TRDizin)

99. Addition of insulin to oral therapy in type 2 diabetes

Dagdelen S.

NEW ENGLAND JOURNAL OF MEDICINE , cilt.358, sa.11, ss.1197, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

100. From Dual Peroxisome Proliferator Activated Receptor Agonists to Selective Peroxisome Proliferator Activated Receptor Modulators

Dagdelen S.

RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY , cilt.2, sa.1, ss.24-28, 2008 (ESCI, Scopus) Sürdürülebilir Kalkınma

101. Pregnancy-induced severe gestational hyperlipidemia mimicking familial hyperlipidemia

BAŞARAN A., DAĞDELEN S., Guerlek A., Bozdag G., Beksac S.

EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY , cilt.136, sa.1, ss.129-130, 2008 (SCI-Expanded, Scopus)

102. Medüller Tiroid Karsinom

FIRAT ÖZER F., DAĞDELEN S.

Endokrinolojide Diyalog Dergisi , cilt.5, sa.4, 2008 (TRDizin)

103. Influence of type 2 diabetes mellitus on bone mineral density response to bisphosphonates in late postmenopausal osteoporosis

Dagdelen S., Sener D., BAYRAKTAR M.

ADVANCES IN THERAPY , cilt.24, sa.6, ss.1314-1320, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

104. Hepatosteatosis with hypobetalipoproteinemia.

D S., S D., T E.

Journal of the National Medical Association , cilt.99, sa.3, ss.284-6, 2007 (Scopus)

105. Hepatosteatosis with hypobetaliploproteinemia

Sen D., Dagdelen S., Erbas T.

JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION , cilt.99, sa.3, ss.284-286, 2007 (SCI-Expanded, Scopus)

106. Asemptomatik primer hiperparatiroidizm

ÖZDEMİR D., DAĞDELEN S., KONCA A. S.

Endokrinolojide Diyalog , cilt.2, ss.147-150, 2007 (Hakemli Dergi)

107. Management and in-hospital outcome of patients with first episode of acute myocardial infarction: Impact of diabetes mellitus

Atmaca A., Dogan S., Dagdelen S., Kabakci G., Kes S., Nazli N., et al.

JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION , cilt.98, sa.11, ss.1752-1757, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

108. Hemorrhage into a thyroid nodule as a cause of thyrotoxicosis.

Onal I. K., Dağdelen S., Atmaca A., Karadağ Ö., Adalar N.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists , cilt.12, sa.3, ss.299-301, 2006 (Scopus)

109. Hyperprolactinemia of pregnancy is not associated with increased in vivo platelet activity and shortened in vitro bleeding times

Atmaca A., Gurlek A., Dagdelen S., Erarslan N., Buyukasik Y., Gultekin M., et al.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , cilt.114, sa.4, ss.188-191, 2006 (SCI-Expanded, Scopus)

110. Follow-up of pregnancy in acromegalic women: Different presentations and outcomes

Atmaca A., Dagdelen S., Erbas T.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , cilt.114, sa.3, ss.135-139, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

111. Rosiglitazone-associated pseudotumour cerebri

Dagdelen S., Gedik O.

DIABETOLOGIA , cilt.49, sa.1, ss.207-208, 2006 (SCI-Expanded, Scopus)

112. Thrombin-activatable fibrinolysis inhibitor activity and global fibrinolytic capacity in type 1 diabetes - Evidence for normal fibrinolytic state

Harmanci A., Kandemir N., Dagdelen S., Gonc N., Buyukasik Y., Alikasifoglu A., et al.

JOURNAL OF DIABETES AND ITS COMPLICATIONS , cilt.20, sa.1, ss.40-44, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

113. Peroxisome proliferator-activated receptor-gamma - Novel therapeutic target linking adiposity, insulin resistance, and atherosclerosis

KEPEZ A., Oto A., Dagdelen S.

BIODRUGS , cilt.20, sa.2, ss.121-135, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

114. Masking effect of endogenous hypercortisolism on vasculitis

Cankurtaran M., Dagdelen S., Apra S., Yildiz B., Kiraz S., Firat P., et al.

ENDOCRINOLOGIST , cilt.15, sa.5, ss.281-285, 2005 (SCI-Expanded, Scopus)

115. Dynamic testing of growth hormone/insulin-like growth factor-1 axis in type 2 diabetes mellitus

Dağdelen S., Gedik O.

DIABETOLOGIA , cilt.48, sa.1, ss.640, 2005 (SCI-Expanded, Scopus)

116. Beneficial effects of octreotide-LAR on serum levels of erythropoetic nutrients in acromegaly

Dagdelen S., Erbas T.

EUROPEAN JOURNAL OF ENDOCRINOLOGY , cilt.152, 2005 (SCI-Expanded, Scopus)

117. Urinary 8-isoprostoglandin F-2 alpha: a new marker in hyperthyroidism?

Aksoy D., Dagdelen S., Gurlek A., Bayraktar M., Adalar N., Purnak T.

PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS , cilt.71, sa.6, ss.411, 2004 (SCI-Expanded, Scopus)

118. Symptomatic treatment of graves hyperthyroidism with lithium in states of thionamide adverse reactions - A retrospective analysis

Atmaca A., Dogan S., Dagdelen S., Gurlek A., Bayraktar M., Adalar N.

ENDOCRINOLOGIST , cilt.14, sa.6, ss.317-320, 2004 (SCI-Expanded, Scopus)

119. Severe hyperglycemia associated with electroconvulsive therapy

Dağdelen S., Akın Atmaca A., Gürlek Ö. A., Tufan A., Güven E., Anıl Yağcıoğlu A. E.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION , cilt.27, ss.615, 2004 (SCI-Expanded, Scopus)

120. Leptomeningeal infiltration of malignant mesothelioma

Oksuzoglu B., Yalcin S., Erman M., Dagdelen S.

MEDICAL ONCOLOGY , cilt.19, sa.3, ss.167-169, 2002 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 33

1. Chronotropic index, heart rate and exercise capacity in diabetes mellitus: comparing two different high-intensity interval training protocols

BOZDEMİR ÖZEL C., ARIKAN H., ÇALIK KÜTÜKCÜ E., DURUKAN B. N., İNAL İNCE D., DAĞDELEN S.

ESC Preventive Cardiology 2024, ATİNA, Yunanistan, 23 - 27 Nisan 2024, cilt.31, ss.278, (Özet Bildiri)

2. The relationship between cardiovascular risk factors and cardiovascular fitness and physical activity in patients with T2DM and prediabetes

ÇALIK KÜTÜKCÜ E., DURUKAN B. N., BOZDEMİR ÖZEL C., ARIKAN H., DAĞDELEN S.

ESC Preventive Cardiology 2024, ATİNA, Yunanistan, 23 - 27 Nisan 2024, cilt.31, ss.69, (Özet Bildiri)

3. RELEASE FACTORS OF BIOFILM-RELATED WOUND PATHOGENS ADVERSELY EFFECT DIABETIC CELLS

Kart D., Dağdelen S., Taşkıran Z. E., Çelebi Saltık B.

International Multidisciplinary Symposium on Drug Research and Development (DRD) 2023, İzmir, Türkiye, 4 - 06 Mayıs 2023, ss.1, (Özet Bildiri)

4. Determinants of peak oxygen pulse in disorders of glucose metabolism

DURUKAN B. N., BOZDEMİR ÖZEL C., ÇALIK KÜTÜKCÜ E., ARIKAN H., DAĞDELEN S.

ESC Preventive Cardiology 2022, PRAG, Çek Cumhuriyeti, 7 - 09 Nisan 2022, cilt.29, (Özet Bildiri)

5. Responses of Two Different High-Intensity Interval Training Protocols in Pulmonary Function and Respiratory Muscle Strength In Diabetes Mellitus

BOZDEMİR ÖZEL C., ARIKAN H., ÇALIK KÜTÜKCÜ E., KARADÜZ B. N., İNAL İNCE D., KABAKCI M. G., et al.

European Respiratory Society International Congress, İsviçre, 5 - 08 Eylül 2021, cilt.58, (Özet Bildiri)

6. Detection of Sex Steroid Expressions in Benign Versus Malignant Adrenal Tumor Tissue Homogenates With Western Blot Analysis

OĞUZ BAYKAL S. H., GÜNAYDIN G., GEDİK M. E., DAĞDELEN S.

ENDO 2021 (Annual Meeting of the Endocrine Society), California, Amerika Birleşik Devletleri, 20 Mart 2021, cilt.5, ss.126, (Tam Metin Bildiri)

7. Bronş astımı olan hastalarda komorbidite düzeyi ve yorgunluk şiddetinin günlük yaşam aktiviteleri ile ilişkisi

BOZDEMİR ÖZEL C., ARIKAN H., DAĞDELEN S., ÇALIK KÜTÜKCÜ E., KARADÜZ B. N., İNAL İNCE D., et al.

7. Ulusal Fizyoterapi ve Rehabilitasyon Kongresi, Türkiye, 18 - 20 Nisan 2019, cilt.30, ss.42, (Özet Bildiri)

8. Akciğer kanserli hastalarda günlük yaşam aktivitelerinin çok boyutlu değerlendirilmesi

BOZDEMİR ÖZEL C., ARIKAN H., DAĞDELEN S., ÇALIK KÜTÜKCÜ E., KARADÜZ B. N., İNAL İNCE D., et al.

7. Ulusal Fizyoterapi ve Rehabilitasyon Kongresi, Türkiye, 18 - 20 Nisan 2019, cilt.30, ss.42, (Özet Bildiri)

9. Diyabetik hastalarda iki farklı yüksek şiddette aralıklı egzersiz: akut cevaplar

BOZDEMİR ÖZEL C., ARIKAN H., DAĞDELEN S., ÇALIK KÜTÜKCÜ E., KARADÜZ B. N., İNAL İNCE D., et al.

7. Ulusal Fizyoterapi ve Rehabilitasyon Kongresi, Türkiye, 18 - 20 Nisan 2019, cilt.30, ss.44, (Özet Bildiri)

10. Somatostatin receptor analogs alter fecal bacterial microbiota in patients with acromegaly: Preliminary results

Şendur S. N., ERGÜNAY K., AKYÖN YILMAZ Y., Brinkmann A., SERDAR M. A., DAĞDELEN S., et al.

18th ENEA (European NeuroEndocrine Association), Wroclaw, Polonya, 17 - 20 Ekim 2018, (Özet Bildiri)

11. Electron Microscopic Findings of Insulin-Induced Local Amyloidosis

Sendur S., Katipoglu K., Kockara O., Gokoz Ö., Kaymaz F., Dagdelen S.

78th Scientific Sessions of the American-Diabetes-Association, Florida, Amerika Birleşik Devletleri, 22 - 26 Haziran 2018, cilt.67, (Özet Bildiri)

12. Prolactinoma Associated with Recurrent Granulomatous Mastitis: A Rare Presentation

ŞENDUR S. N., BAHÇECİOĞLU MUTLU A. B., BAYKAL R. G., DAĞDELEN S., SÖYLEMEZOĞLU A. F., ERBAŞ A. T.

5th ENEA Workshop “Hyperprolactinemia and other endocrine causes of infertility”, St Petersburg, Rusya, 7 - 09 Eylül 2017, (Özet Bildiri)

13. Glycaemic variability is associated with oxidative damage independently from glycaemic control in type 1 diabetes

Dagdelen S., Bahcecioglu A. B., Lay I., Samadi A., Unluturk U., Bayraktar M.

53rd Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Lisbon, Portekiz, 11 - 15 Eylül 2017, (Özet Bildiri)

14. Association between Klotho gene polymorphisms, circulating Klotho and FGF23 levels and echocardiographic parameters among patients with acromegaly.

NAFİYE H., HEKİMSOY V., KABACAM S., LAY İ., ŞENER Y. Z., DAĞDELEN S., et al.

ENDO 2017, The Endocrine Society’s 99th Annual Meeting and Expo., Orlando, Amerika Birleşik Devletleri, 1 - 04 Nisan 2017, cilt.38, (Özet Bildiri)

15. TERSİYER HİPERPARATİROİDİDECERRAHİ TEDAVİ Mİ? CİNACALCET Mİ?HACETTEPE ÜNİVERSİTESİ DENEYİMİ

SAVAŞ E. M., ÜNLÜTÜRK U., YILDIRIM T., EYÜPOĞLU N. D., SELİMOVA C., YILMAZ Ş. R., et al.

39. TÜRKİYE ENDOKRİNOLOJİ VE METABOLİZMA HASTALIKLARI KONGRESİ, Türkiye, 3 - 07 Mayıs 2017, (Özet Bildiri)

16. Mauriac’s Syndrome Caused by Munchausen Syndrome-Associated Insulin Abuse in Type 1 Diabetes Mellitus

ŞENDUR S. N., DAĞDELEN S., ÜNLÜTÜRK U., ERBAŞ A. T., BAYRAKTAR M.

The Endocrine Society’xxs 99 th Annual Meeting, ORLANDO, Amerika Birleşik Devletleri, 1 - 04 Nisan 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

17. Surgery or Medical Treatment: Management of a Patient with Giant Cystic Prolactinoma

OĞUZ S. H., ÖGE H. K., SÖYLEMEZOĞLU A. F., KARLI OĞUZ H. K., DAĞDELEN S., ERBAŞ A. T.

The Endocrine Society’xxs 99 th Annual Meeting, ORLANDO, Amerika Birleşik Devletleri, 1 - 04 Nisan 2017, (Özet Bildiri)

18. Karbonhidrat sayımı tip 1 diyabeti tip 2’lileştirir mi? Retrospektif 10 yıllık izlem sonuçları

OĞUZ S. H., ÜNLÜTÜRK U., AKIN Ş., DAĞDELEN S.

1. DİYABET TEKNOLOJİLERİ SEMPOZYUMU, Türkiye, 20 - 22 Ocak 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

19. KLOTHO GENE POLYMORPHISM A NOVEL PREDICTIVE MARKER FOR CANCER IN ACROMEGALIC PATIENTS

HELVACI N., kabaçam s., ŞENER Y. Z., DAĞDELEN S., MUT AŞKUN M., ALİKAŞİFOĞLU M., et al.

European Neuroendocrine Association Congress 2016, Milan, İtalya, 19 - 22 Ekim 2016, (Özet Bildiri) Sürdürülebilir Kalkınma

20. Atypical pituitary adenoma associated with thyroid and parathyroid cancer a uique entity

OĞUZ S. H., SÖYLEMEZOĞLU A. F., DAĞDELEN S., ERBAŞ A. T.

17th congress of the European Neuroendocrine Association, 19 - 22 Ekim 2016, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

21. Parathyroid carcinoma a case series of 20 patients

BAHÇECİOĞLU A. B., HELVACI N., DAĞDELEN S., KAYNAROĞLU Z. V., Erbaş B., SÖKMENSÜER C., et al.

17th international congress of endocrinology, 31 Ağustos - 04 Eylül 2016, (Özet Bildiri)

22. Does IGF2BP2 gene polymorphism have an effect on the development of gestational diabetes mellitus

Çıkman D. İ., Çıkman M. S., ALİKAŞİFOĞLU M., DAĞDELEN S.

18th European Congress of Endocrinology, 28 - 31 Mayıs 2016, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

23. Nivolumab associated thyroiditis in a patient with non small cell lung cancer

ŞENDUR A., ŞENDUR S. N., DEMİRKAZIK A., DAĞDELEN S., ERBAŞ A. T.

18th European Congress of Endocrinology, Munich, Almanya, 28 - 31 Mayıs 2016, (Tam Metin Bildiri)

24. A novel mutation of the menin gene in a family with multiple endocrine neoplasia type 1

Şendur S. N., DOĞRUL A. B., Kabaçam S., ABBASOĞLU O., ÖNDER S. Ç., SÖKMENSÜER C., et al.

18th European Congress of Endocrinology, 28 - 31 Mayıs 2016, (Tam Metin Bildiri)

25. A Case of Young Male Patient with Men 1 Syndrome Who Had Chest Pain Hypocalcemia and Elevated Cardiac Biomarkers after Parathyroidectomy Mimicking Acute Coronary Syndrome

Şendur S. N., EVRANOS B., DOĞRUL A. B., ABBASOĞLU O., DAĞDELEN S., ERBAŞ A. T.

The Endocrine Society's 98'th Annual Meeting, Boston, Amerika Birleşik Devletleri, 1 - 04 Nisan 2016, (Tam Metin Bildiri)

26. Cases of acromegaly associated with multiple malignant tumors

HELVACI N., Şafak A., DAĞDELEN S., KAYNAROĞLU Z. V., ERBAŞ A. T.

4th European Neuroendocrine association, 10 - 12 Aralık 2015

27. Succesful pregnancy in acromegalic patients

HELVACI N., süleyman nahit ş., DAĞDELEN S., ERBAŞ A. T.

4. European Neuroendocrine Association Workshop, 10 - 12 Aralık 2015

28. Abdominal Thoracic and Cranial Aneursyms in Patients with Acromegaly See more at http press endocrine org doi abs 10 1210 endo meetings 2015 NP 16 OR20 6 sthash D2bYKlwO dpuf

DAĞDELEN S., Safak A., GÜMELER E., ÖZGEN MOCAN B., ERBAŞ A. T.

97'TH ANNUAL MEETING OF ENDOCRINE SOCIETY, 5 - 08 Mart 2015, (Tam Metin Bildiri)

29. Association Between ACE and AGT Polymorphism and Cardiovascular Risk in Acromegalic Patients

ERBAŞ A. T., DAĞDELEN S., GEDİK A., YORGUN H., CANPOLAT U., KABAKCI M. G.

16th International Congress of Endocrinology. ICE/ENDO 2014, 21-24 June, 2014; Chicago, US., 21 - 24 Haziran 2014

30. Diagnosis of Acromegaly: Results from 100 Patients Followed in a Single Center.

Aydin K., Cinar N. U., DAĞDELEN S., Erbas T.

92nd Meeting and Expo of the Endocrine Society (ENDO 2010), California, Amerika Birleşik Devletleri, 19 - 22 Haziran 2010, cilt.31, (Özet Bildiri)

31. Spontaneous Remission of Acromegaly after Infarctive Apoplexy with a Possible Relation to MRI and Diabetes Mellitus.

Cinar N. U., METİN Y., DAĞDELEN S., Ziyal M. I., Soylemezoglu F., Erbas T.

92nd Meeting and Expo of the Endocrine Society (ENDO 2010), California, Amerika Birleşik Devletleri, 19 - 22 Haziran 2010, cilt.31, (Özet Bildiri) Sürdürülebilir Kalkınma